Print Email

MASCC Antiemetics Study Group


Leadership
Co-chair: Matti Aapro, MD - Switzerland
Co-chair: Alexander Molassiotis, RN,MSc, PhD - Hong Kong

Study Group Minutes
2010 Minutes (PDF) - Vancouver, Canada

Guidelines Guidelines & Assessment Tools

Latest Updates
MAT - Now available on the iphone in the App Store
alt

History and Purpose

The Antiemetic Study Group was originally established as a subcommittee of MASCC to address the control of nausea and vomiting induced by chemotherapy and radiotherapy. At the 1995 MASCC Annual Meeting in Luxembourg, the group organized a consensus conference on the use of antiemetics. To identify the most important topics on which consensus should be measured and developed, the group constructed a questionnaire and circulated it to experts. The results, published in Supportive Care in Cancer, identified eight major issues that served as the basis for the conference (Ballatori et al, Support Care Cancer 1997; 5: 269-273). The Consensus Conference was held in Perugia, Italy, 28-29 April 1997, and results were published in the ESMO journal, Annals of Oncology (Ann Oncol.1998; 9: 811-819).

In the following years, the Study Group has worked in two directions. First, because various guideline recommendations for antiemetic prophylaxis (from, for example, the ASCO, ESMO, MASCC, NCON, and ASHP) differed, a unified consensus conference was held in New York. 19-20 April 2001. The final document of the conference was presented during the ASCO-MASCC Joint Session held in San Francisco, 14 May, 2001. 

Second, the members of the Study Group have always been most concerned about the moderate transfer of knowledge from clinical trials to clinical practice. The Study Group thus planned an international drug utilization study to study antiemetic prescriptions and effectiveness with respect to delayed emesis induced by chemotherapy. Despite optimal prophylaxis, this remains one of the unsolved problems of antiemetic therapy.

 

alt

alt

A Guide to Oncology Symptom Management 
Edited by C.G. Brown. 2010 20% MASCC Discount. This best-selling book offers a complete overview of common symptoms and problems that affect patients with cancer. Topics include common symptoms such as chemotherapy-induced nausea and vomiting, cancer-related fatigue, and oral mucositis, as well as symptoms in older adults.

Books on Supportive Care  >>VIEW ALL - MASCC Member Discountsalt

MASCC Endorsed Guideline Partnerships

Acute AINV Guideline
The Pediatric Oncology Group of Ontario (POGO) has published “Guideline for the Prevention of Acute Nausea and Vomiting due to Antineoplastic Medication in Pediatric Cancer Patients” (April 2014). The purpose of this guideline is to provide healthcare providers with an approach to the prevention of acute antineoplastic-induced nausea and vomiting (AINV) in children. The scope is limited to the prevention of AINV in the acute phase (within 24 hours of antineoplastic administration). >> Quick Review Summary

alt

MASCC Study Group Coordinator, Anne Young

 

 

 

 

 
powered by MemberClicks